Whole blood transcriptional variations between responders and non-responders in asthma patients receiving omalizumab

Katherine Upchurch; Matthew Wiest; Jacob Cardenas; Jason Skinner; Durgha Nattami; Bobby Lanier; Mark Millard; Hye Mee Joo; Jacob Turner; Sang Kon Oh

doi:10.1111/cea.13671

Whole blood transcriptional variations between responders and non-responders in asthma patients receiving omalizumab

Katherine Upchurch, Matthew Wiest, Jacob Cardenas, Jason Skinner, Durgha Nattami, Bobby Lanier, Mark Millard, Hye Mee Joo, Jacob Turner, Sang Kon Oh

Mathematics and Statistics

Producción científica: Article › revisión exhaustiva

Idioma original	English
Páginas (desde-hasta)	1017-1034
Número de páginas	18
Publicación	Clinical and Experimental Allergy
Volumen	50
N.º	9
DOI	https://doi.org/10.1111/cea.13671
Estado	Published - sept 1 2020

ASJC Scopus Subject Areas

Immunology and Allergy
Immunology

Acceder al documento

10.1111/cea.13671

Otros archivos y enlaces

Citar esto

@article{bafd54dbfd974a88b2b54de1e36854c7,

title = "Whole blood transcriptional variations between responders and non-responders in asthma patients receiving omalizumab",

keywords = "anti-IgE, asthma, transcriptome, biomarkers, omalizumab",

author = "Katherine Upchurch and Matthew Wiest and Jacob Cardenas and Jason Skinner and Durgha Nattami and Bobby Lanier and Mark Millard and Joo, {Hye Mee} and Jacob Turner and Oh, {Sang Kon}",

note = "Publisher Copyright: {\textcopyright} 2020 John Wiley & Sons Ltd",

year = "2020",

month = sep,

day = "1",

doi = "10.1111/cea.13671",

language = "English",

volume = "50",

pages = "1017--1034",

number = "9",

}

TY - JOUR

T1 - Whole blood transcriptional variations between responders and non-responders in asthma patients receiving omalizumab

AU - Upchurch, Katherine

AU - Wiest, Matthew

AU - Cardenas, Jacob

AU - Skinner, Jason

AU - Nattami, Durgha

AU - Lanier, Bobby

AU - Millard, Mark

AU - Joo, Hye Mee

AU - Turner, Jacob

AU - Oh, Sang Kon

PY - 2020/9/1

Y1 - 2020/9/1

KW - anti-IgE

KW - asthma, transcriptome

KW - biomarkers

KW - omalizumab

UR - http://www.scopus.com/inward/record.url?scp=85087919788&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85087919788&partnerID=8YFLogxK

U2 - 10.1111/cea.13671

DO - 10.1111/cea.13671

M3 - Article

C2 - 32472607

AN - SCOPUS:85087919788

SN - 0954-7894

VL - 50

SP - 1017

EP - 1034

JO - Clinical and Experimental Allergy

JF - Clinical and Experimental Allergy

IS - 9

ER -